VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
LQDALiquidia Corporation
$71.07$6.3B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

LQDA logoLiquidia Corporation(LQDA)Earnings, Financials & Key Ratios

LQDA•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryCommercial Specialty Pharma
AboutLiquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.Show more
  • Revenue$158M+1031.2%
  • EBITDA-$50M+58.1%
  • Net Income-$69M+47.1%
  • EPS (Diluted)-0.80+51.8%
  • Gross Margin91.64%+58.0%
  • EBITDA Margin-31.49%+96.3%
  • Operating Margin-32.45%+96.3%
  • Net Margin-43.53%+95.3%
  • ROE-112.97%+46.0%

LQDA Key Insights

Liquidia Corporation (LQDA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 96 (top 4%)
  • ✓Strong 5Y sales CAGR of 192.5%
  • ✓Trading near 52-week high

✗Weaknesses

  • ✗High debt to equity ratio of 4.4x
  • ✗Negative free cash flow
  • ✗Expensive at 136.7x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when LQDA posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

LQDA Price & Volume

Liquidia Corporation (LQDA) stock price & volume — 10-year historical chart

Loading chart...

LQDA Growth Metrics

Liquidia Corporation (LQDA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years192.49%
3 Years114.98%
TTM1936.66%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM117.45%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM108.86%

Return on Capital

10 Years-89.1%
5 Years-50.82%
3 Years-59.26%
Last Year-26.99%

LQDA Recent Earnings

Liquidia Corporation (LQDA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 11, 2026
Metric
Actual
Est
EPS
$0.52+52.9%
$0.34
Rev
$133M+11.2%
$119M
Q2 2026
Mar 5, 2026
Metric
Actual
Est
EPS
$0.15+87.5%
$0.08
Rev
$92M+3.9%
$89M
Q4 2025
Nov 3, 2025
Metric
Actual
Est
EPS
$0.04+91.1%
$0.45
Rev
$54M-32.7%
$81M
Q3 2025
Aug 12, 2025
Metric
Actual
Est
EPS
$0.49-14.0%
$0.43
Rev
$9M-38.2%
$14M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 11, 2026
$0.52vs $0.34+52.9%
$133Mvs $119M+11.2%
Q2 2026Mar 5, 2026
$0.15vs $0.08+87.5%
$92Mvs $89M+3.9%
Q4 2025Nov 3, 2025
$0.04vs $0.45+91.1%
$54Mvs $81M-32.7%
Q3 2025Aug 12, 2025
$0.49vs $0.43-14.0%
$9Mvs $14M-38.2%
Based on last 12 quarters of dataView full earnings history →

LQDA Peer Comparison

Liquidia Corporation (LQDA) competitors in Commercial Specialty Pharma — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
UTHR logoUTHRUnited Therapeutics CorporationDirect Competitor22.78B536.5919.2610.61%40.61%19.24%
MNKD logoMNKDMannKind CorporationDirect Competitor1.22B3.9419722.23%-6.63%
INVA logoINVAInnoviva, Inc.Direct Competitor1.66B22.496.8218.52%118.91%47.59%0.23
PRAX logoPRAXPraxis Precision Medicines, Inc.Direct Competitor8.15B282.31-20.94-100%-43.02%0.00
INSM logoINSMInsmed IncorporatedProduct Competitor20.76B95.80-14.9566.73%-144.44%-130.11%1.04
NKTR logoNKTRNektar TherapeuticsProduct Competitor1.19B60.98-6.27-43.89%-284.18%-87%1.66
PBYI logoPBYIPuma Biotechnology, Inc.Product Competitor384.8M7.5612.39-0.91%10.73%20.37%0.22
KALA logoKALAKALA BIO, Inc.Product Competitor79.17M3.61-1.09-13.36%

Compare LQDA vs Peers

Liquidia Corporation (LQDA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs UTHR

Most directly comparable listed peer for LQDA.

Scale Benchmark

vs JNJ

Larger-name benchmark to compare LQDA against a more recognizable public peer.

Peer Set

Compare Top 5

vs UTHR, MNKD, INVA, PRAX

LQDA Income Statement

Liquidia Corporation (LQDA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
7.26M2.71M8.07M739.63K12.85M15.94M17.49M14M158.32M288.06M
Revenue Growth %
-45.08%-62.7%198.2%-90.84%1637.77%23.98%9.75%-19.97%1031.18%1936.66%
Cost of Goods Sold
319.76K121.39K807.19K237.71K3.02M2.86M2.89M5.88M13.24M23.67M
COGS % of Revenue
4.41%4.48%10%32.14%23.52%17.94%16.51%42%8.36%-
Gross Profit
6.94M▲ 0%
2.59M▼ 62.7%
7.26M▲ 181.0%
501.92K▼ 93.1%
9.83M▲ 1858.5%
13.08M▲ 33.0%
14.6M▲ 11.7%
8.12M▼ 44.4%
145.08M▲ 1687.3%
264.4M▲ 0%
Gross Margin %
95.59%95.52%90%67.86%76.48%82.06%83.49%58%91.64%91.78%
Gross Profit Growth %
-43.58%-62.73%180.98%-93.09%1858.49%33.02%11.65%-44.4%1687.34%-
Operating Expenses
34.97M37.45M54.09M59.59M43.63M51.85M87.98M129.41M196.45M218.84M
OpEx % of Revenue
481.76%1383.6%670.07%8056.89%339.43%325.36%503.11%924.63%124.09%-
Selling, General & Admin
10.21M8.75M13.6M27.37M23.11M32.41M44.74M81.57M157.18M174.05M
SG&A % of Revenue
140.71%323.39%168.45%3700.33%179.8%203.39%255.84%582.8%99.28%-
Research & Development
24.75M28.7M40.49M32.22M20.52M19.43M43.24M47.84M39.28M44.58M
R&D % of Revenue
341.05%1060.21%501.62%4356.57%159.63%121.96%247.27%341.83%24.81%-
Other Operating Expenses
000000000205K
Operating Income
-28.03M▲ 0%
-34.87M▼ 24.4%
-46.82M▼ 34.3%
-59.09M▼ 26.2%
-33.8M▲ 42.8%
-38.77M▼ 14.7%
-73.38M▼ 89.3%
-121.29M▼ 65.3%
-51.38M▲ 57.6%
45.55M▲ 0%
Operating Margin %
-386.16%-1288.08%-580.07%-7989.03%-262.95%-243.3%-419.62%-866.63%-32.45%15.81%
Operating Income Growth %
-76.69%-24.4%-34.29%-26.2%42.8%-14.71%-89.28%-65.29%57.64%-
EBITDA
-27.1M-33.32M-44.03M-55.97M-28.18M-35.12M-71.21M-119.1M-49.85M47.13M
EBITDA Margin %
-373.32%-1231.05%-545.46%-7567.72%-219.29%-220.41%-407.17%-850.94%-31.49%16.36%
EBITDA Growth %
-78.13%-22.98%-32.13%-27.12%49.65%-24.62%-102.73%-67.26%58.15%137.47%
D&A (Non-Cash Add-back)
931.93K1.54M2.79M3.12M5.61M3.65M2.18M2.2M1.53M1.57M
EBIT
-16.14M-34.15M-46.21M-58.9M-33.82M-38.68M-72.23M-117.91M-44.75M50.45M
Net Interest Income
-13.01M-18.68M-759.91K-673.64K-729K-1.25M-2.81M-4.83M-17.55M-19.33M
Interest Income
268304.98K613.72K184.36K33K1.09M3.47M7.65M6.62M6.67M
Interest Expense
13.01M18.99M1.37M858K762K2.34M6.27M12.49M24.17M26M
Other Income/Expense
-1.13M-18.27M-759.91K-673.64K-782K-2.25M-5.12M-9.1M-17.55M-19.33M
Pretax Income
-29.15M▲ 0%
-53.14M▼ 82.3%
-47.58M▲ 10.4%
-59.76M▼ 25.6%
-34.58M▲ 42.1%
-41.02M▼ 18.6%
-78.5M▼ 91.4%
-130.39M▼ 66.1%
-68.92M▲ 47.1%
26.23M▲ 0%
Pretax Margin %
-401.68%-1962.92%-589.48%-8080.11%-269.03%-257.39%-448.89%-931.65%-43.53%9.1%
Income Tax
0000000003.92M
Effective Tax Rate %
0%0%0%0%0%0%0%0%0%14.95%
Net Income
-29.15M▲ 0%
-53.14M▼ 82.3%
-47.58M▲ 10.4%
-59.76M▼ 25.6%
-34.58M▲ 42.1%
-41.02M▼ 18.6%
-78.5M▼ 91.4%
-130.39M▼ 66.1%
-68.92M▲ 47.1%
22.3M▲ 0%
Net Margin %
-401.68%-1962.92%-589.48%-8080.11%-269.03%-257.39%-448.89%-931.65%-43.53%7.74%
Net Income Growth %
-82.97%-82.26%10.45%-25.6%42.14%-18.61%-91.4%-66.1%47.14%117.45%
Net Income (Continuing)
-29.15M-53.14M-47.58M-59.76M-34.58M-41.02M-78.5M-130.39M-68.92M22.3M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-3.40▲ 0%
-7.42▼ 118.2%
-2.51▲ 66.2%
-1.76▲ 29.9%
-0.70▲ 60.2%
-0.67▲ 4.3%
-1.21▼ 80.6%
-1.66▼ 37.2%
-0.80▲ 51.8%
0.22▲ 0%
EPS Growth %
-82.8%-118.24%66.17%29.88%60.23%4.29%-80.6%-37.19%51.81%108.86%
EPS (Basic)
-3.40-7.42-2.51-1.76-0.70-0.67-1.21-1.66-0.80-
Diluted Shares Outstanding
8.59M7.16M18.48M33.89M49.68M60.96M64.99M78.71M86.06M101.11M
Basic Shares Outstanding
8.59M7.16M18.48M33.89M49.68M60.96M64.99M78.71M86.06M88.01M
Dividend Payout Ratio
----------

LQDA Balance Sheet

Liquidia Corporation (LQDA) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
5.48M40.03M56.39M66.07M61.28M99.81M89.9M185.1M190.68M333.06M
Cash & Short-Term Investments
3.42M39.53M55.8M65.32M57.49M93.28M83.68M176.48M190.68M222.79M
Cash Only
3.42M39.53M55.8M65.32M57.49M93.28M83.68M176.48M190.68M222.79M
Short-Term Investments
0000000000
Accounts Receivable
1.62M272.56K002.99M5.02M4.06M2.72M54.09M74.16M
Days Sales Outstanding
81.5836.75--84.91114.9284.7670.91124.7155.17
Inventory
0000000241K028.51M
Days Inventory Outstanding
-------14.96-229.33
Other Current Assets
0000-3811.51M2.16M5.67M-54.09M7.61M
Total Non-Current Assets
9.36M9.39M12.46M33.46M32.45M29.39M28.43M45.21M137.25M68.48M
Property, Plant & Equipment
8.24M8.13M12.08M9.45M7.43M6.25M6.18M12.48M025.2M
Fixed Asset Turnover
0.88x0.33x0.67x0.08x1.73x2.55x2.83x1.12x-21.53x
Goodwill
0003.9M3.9M3.9M3.9M3.9M3.9M3.9M
Intangible Assets
0005.53M4.39M3.73M3.43M3.16M2.95M2.89M
Long-Term Investments
000000003.5M14.02M
Other Non-Current Assets
1.12M1.26M378.04K14.57M16.73M15.51M14.92M25.66M126.89M32.12M
Total Assets
14.84M▲ 0%
49.42M▲ 232.9%
68.84M▲ 39.3%
99.53M▲ 44.6%
93.73M▼ 5.8%
129.2M▲ 37.8%
118.33M▼ 8.4%
230.31M▲ 94.6%
327.93M▲ 42.4%
401.53M▲ 0%
Asset Turnover
0.49x0.05x0.12x0.01x0.14x0.12x0.15x0.06x0.48x0.91x
Asset Growth %
74.91%232.93%39.3%44.58%-5.83%37.84%-8.41%94.63%42.39%173.21%
Total Current Liabilities
30.52M8.25M16.87M11.74M7.33M8.8M18.55M41.78M135.77M149.74M
Accounts Payable
4.42M3.24M3.5M3.73M1.07M2.2M1.4M4.69M3.68M10.98M
Days Payables Outstanding
5.05K9.73K1.58K5.73K129.19280.48176.43291.12101.38123.46
Short-Term Debt
15.61M316.91K5.59M0002.62M18.02M58.89M51.03M
Deferred Revenue (Current)
3.61M8.07B00000000
Other Current Liabilities
2.22M268.6K1.29M5.03M3.16M2.86M8.54M18.66M73.2M77.85M
Current Ratio
0.18x4.85x3.34x5.63x8.36x11.34x4.85x4.43x1.40x2.22x
Quick Ratio
0.18x4.85x3.34x5.63x8.36x11.34x4.85x4.42x1.40x2.03x
Cash Conversion Cycle
--------205.25-161.04
Total Non-Current Liabilities
18.01M22.48M17.02M16.71M21.14M29.98M52.49M111.26M147.42M143.21M
Long-Term Debt
5.56M11.63M10.29M10.29M10.41M19.88M43.42M97.37M132.94M127.64M
Capital Lease Obligations
510.63K376.08K6.73M5.26M4.58M3.5M2.36M6.59M6.1M24.88M
Deferred Tax Liabilities
-510.63K-376.08K0000003.63M873K
Other Non-Current Liabilities
6.42M2.41M01.15M6.14M6.59M6.71M7.3M4.75M8.55M
Total Liabilities
48.54M30.73M33.89M28.45M28.46M38.78M71.04M153.04M283.19M292.95M
Total Debt
22.15M12.77M24.42M17.14M16.08M24.46M49.54M122.39M197.93M184.82M
Net Debt
18.73M-26.76M-31.38M-48.17M-41.41M-68.82M-34.14M-54.09M7.25M-37.96M
Debt / Equity
-0.68x0.70x0.24x0.25x0.27x1.05x1.58x4.42x1.70x
Debt / EBITDA
---------3.92x
Net Debt / EBITDA
----------0.81x
Interest Coverage
-1.24x-1.80x-33.64x-68.65x-44.38x-16.54x-11.51x-9.44x-1.85x1.94x
Total Equity
-33.69M▲ 0%
18.69M▲ 155.5%
34.95M▲ 87.0%
71.09M▲ 103.4%
65.27M▼ 8.2%
90.42M▲ 38.5%
47.29M▼ 47.7%
77.28M▲ 63.4%
44.75M▼ 42.1%
108.58M▲ 0%
Equity Growth %
-84.66%155.47%87.01%103.41%-8.19%38.55%-47.7%63.4%-42.09%-79.51%
Book Value per Share
-3.922.611.892.101.311.480.730.980.521.07
Total Shareholders' Equity
-33.69M18.69M34.95M71.09M65.27M90.42M47.29M77.28M44.75M108.58M
Common Stock
57015.52K28.23K43.34K52K64K69K85K87K88K
Retained Earnings
-113.41M-167.05M-215.24M-275M-309.58M-350.6M-429.1M-559.49M-626.31M-573.45M
Treasury Stock
0000000000
Accumulated OCI
-7.8M-9.3M00000000
Minority Interest
0000000000

LQDA Cash Flow Statement

Liquidia Corporation (LQDA) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-24.29M-31.83M-48.28M-54.14M-34.03M-28.59M-41.56M-93.42M-35.69M47.98M
Operating CF Margin %
-334.66%-1175.87%-598.14%-7320.51%-264.8%-179.4%-237.67%-667.49%-22.54%-
Operating CF Growth %
-74.17%-31.04%-51.69%-12.14%37.14%16%-45.39%-124.77%61.8%572.13%
Net Income
-29.15M-53.14M-47.58M-59.76M-34.58M-41.02M-78.5M-130.39M-68.92M22.3M
Depreciation & Amortization
931.93K1.54M2.57M3.13M5.61M3.65M2.18M2.2M1.53M1.57M
Stock-Based Compensation
514.09K2.2M3.38M3.95M6.75M9.3M10.09M18.81M29.47M31.25M
Deferred Taxes
-11.88M-415.41K6.59K10.8K000000
Other Non-Cash Items
14.91M17.69M300.9K235.53K566K1.64M18.8M20.76M26.42M27.78M
Working Capital Changes
389.67K294.85K-6.95M-1.71M-12.38M-2.16M5.87M-4.79M-24.18M-34.93M
Change in Receivables
-328.46K1.35B272.56K0-2.99M-2.03M956K1.34M-51.37M-72.91M
Change in Inventory
0-1.35B-272.56K0000-241K-22.99M-26.45M
Change in Payables
1.87M-1.28M294.51K-297.16K-7.56M814K-1.15M2.33M-2.59M-5.45M
Cash from Investing
-2.54M-870.94K-1.85M247.91K-107K-587K-11.29M-8.44M-6.34M-8.84M
Capital Expenditures
-2.54M-870.94K-1.85M-752.09K-107K-592K-1.29M-4.95M-4.34M-6.84M
CapEx % of Revenue
35.05%32.17%22.92%101.68%0.83%3.72%7.38%35.36%2.74%2.37%
Acquisitions
0001M05K0000
Investments
----------
Other Investing
000000-10M-3.49M-2M-2M
Cash from Financing
28.81M68.82M66.39M63.42M26.32M64.96M43.25M194.66M59.73M17.39M
Debt Issued (Net)
30.12M-1.43M3.97M-6.77M-420K8.96M19.37M52.5M53.82M11.06M
Equity Issued (Net)
072.43M62.43M71.23M21.71M54.46M24.24M138.55M4.82M5.31M
Dividends Paid
0000000000
Share Repurchases
0000000000
Other Financing
-1.3M-2.18M0-1.04M5.03M1.55M-363K3.61M1.08M1.01M
Net Change in Cash
1.98M▲ 0%
36.12M▲ 1723.8%
16.26M▼ 55.0%
9.52M▼ 41.5%
-7.82M▼ 182.2%
35.79M▲ 557.5%
-9.6M▼ 126.8%
92.8M▲ 1066.3%
14.2M▼ 84.7%
56.53M▲ 0%
Free Cash Flow
-26.83M▲ 0%
-32.7M▼ 21.9%
-50.13M▼ 53.3%
-54.9M▼ 9.5%
-34.14M▲ 37.8%
-29.18M▲ 14.5%
-42.85M▼ 46.9%
-98.37M▼ 129.5%
-40.02M▲ 59.3%
41.15M▲ 0%
FCF Margin %
-369.72%-1208.04%-621.06%-7422.19%-265.63%-183.12%-245.05%-702.85%-25.28%14.28%
FCF Growth %
-59.43%-21.86%-53.3%-9.5%37.81%14.53%-46.86%-129.55%59.32%138.32%
FCF per Share
-3.13-4.57-2.71-1.62-0.69-0.48-0.66-1.25-0.470.41
FCF Conversion (FCF/Net Income)
0.83x0.60x1.01x0.91x0.98x0.70x0.53x0.72x0.52x1.84x
Interest Paid
0000423K00000
Taxes Paid
0000000000

LQDA Key Ratios

Liquidia Corporation (LQDA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
--284.34%-177.43%-112.72%-50.72%-52.69%-114.01%-209.35%-112.97%46.82%
Return on Invested Capital (ROIC)
----334.73%-108.41%-127.95%-316.75%-500.72%-102.5%59.81%
Gross Margin
95.59%95.52%90%67.86%76.48%82.06%83.49%58%91.64%91.78%
Net Margin
-401.68%-1962.92%-589.48%-8080.11%-269.03%-257.39%-448.89%-931.65%-43.53%7.74%
Debt / Equity
-0.68x0.70x0.24x0.25x0.27x1.05x1.58x4.42x1.70x
Interest Coverage
-1.24x-1.80x-33.64x-68.65x-44.38x-16.54x-11.51x-9.44x-1.85x1.94x
FCF Conversion
0.83x0.60x1.01x0.91x0.98x0.70x0.53x0.72x0.52x1.84x
Revenue Growth
-45.08%-62.7%198.2%-90.84%1637.77%23.98%9.75%-19.97%1031.18%1936.66%
Related:LQDA Dividend History·LQDA Revenue History·LQDA Price History·LQDA P/E History·LQDA Financial Ratios·LQDA Institutional Holders

LQDA SEC Filings & Documents

Liquidia Corporation (LQDA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 11, 2026·SEC

Material company update

Mar 5, 2026·SEC

Material company update

Jan 9, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 5, 2026·SEC

FY 2025

Mar 19, 2025·SEC

10-Q Quarterly Reports

5
FY 2026

May 11, 2026·SEC

FY 2025

Nov 3, 2025·SEC

FY 2025

Aug 12, 2025·SEC

LQDA Frequently Asked Questions

Liquidia Corporation (LQDA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Liquidia Corporation (LQDA) reported $288.1M in revenue for fiscal year 2025. This represents a 2080% increase from $13.2M in 2016.

Liquidia Corporation (LQDA) grew revenue by 1031.2% over the past year. This is strong growth.

Yes, Liquidia Corporation (LQDA) is profitable, generating $22.3M in net income for fiscal year 2025 (-43.5% net margin).

Dividend & Returns

Liquidia Corporation (LQDA) has a return on equity (ROE) of -113.0%. Negative ROE indicates the company is unprofitable.

Liquidia Corporation (LQDA) generated $41.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in LQDA back in 2016?

Total return calculator · dividends reinvested · 10+ years of data

See returns →

How much would $100/month in LQDA be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →